KRTAP13-5P

Across TCGA pan-cancer cohorts, KRTAP13-5P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated KRTAP13-5P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher KRTAP13-5P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRTAP13-5P expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

LIHC, STAD, and BLCA are the cancer types where KRTAP13-5P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.183	0.786	<.001	90	view →
STAD	OS	Tertile	All	0.266	0.739	<.001	72	view →
BLCA	DFS	Tertile	All	0.219	0.617	.007	45	view →
KIRC	DFS	Tertile	IV	0.090	0.641	<.001	36	view →
OV	DFS	Tertile	III,IV	1.000	0.151	.025	36	view →
GBM	OS	Tertile	All	0.062	0.416	.001	27	view →
COAD	DFS	Tertile	All	0.235	0.790	.010	18	view →
UCEC	OS	Tertile	All	0.780	0.927	.030	18	view →
SKCM	DFS	Tertile	All	0.226	0.757	.037	15	view →
PRAD	DFS	Tertile	All	0.765	0.892	.028	12	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

KRTAP13-5P–LIHC (OS)

Open the LIHC breakdown →